In addition, Cubist may not be consulted concerning any matters that could cause a delay in completion of the Facility.
Cubist may not terminate terminate this Agreement even in the event that the FDA refuses to approve the Product.
(b) Cubist may ne required to pay DSM for any Product which has been properly rejected in accordance with clause 3.11 sub (a).
Cubist may not be, at all times and upon reasonable notice and normal business hours, denied an inspection of the Facility to ascertain compliance with GMPs.
